Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 55.45 % )
Last Price $0.319 1.92 %
High/ Low $0.300 - $0.328 9.33%
Chg 7 Days -1.85 % $0.325 $0.319
Chg 30 Days -27.66 % $0.441 $0.319
Chg 12 mos -87.82 % $2.62 $0.319
Trend - 3 mos -50.58 % Width: 265.06 %
Trend - 12 mos -82.93 % Width: 279.28 %
Pred. range - 3 mos $0.0722 - $0.263 -77.37 % - -17.40 %
Pred. range - 12 mos N/A - $0.121 -100.00 % - -62.18 %
Short MA avg 3 mos Buy 2022-05-26 - 2 days
Long MA avg 3 mos Sell 2022-04-06 - 37 days
Short/Long MA avg 3 mos Sell 2022-04-11 - 34 days
Short MA avg 12 mos Buy 2022-05-17 - 9 days
Long MA avg 12 mos Sell 2021-09-03 - 185 days
Short/Long MA avg 12 mos Sell 2021-09-10 - 181 days
Pivot Short Buy 2022-05-25 - 3 days
Bollinger Sell 0000-00-00 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT